• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SARS-CoV-2 incidence and vaccine escape.

作者信息

Thompson Robin N, Hill Edward M, Gog Julia R

机构信息

Mathematics Institute, University of Warwick, Coventry, UK; Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, University of Warwick, Coventry, UK.

Mathematics Institute, University of Warwick, Coventry, UK; Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, University of Warwick, Coventry, UK; School of Life Sciences, University of Warwick, Coventry, UK.

出版信息

Lancet Infect Dis. 2021 Jul;21(7):913-914. doi: 10.1016/S1473-3099(21)00202-4. Epub 2021 Apr 13.

DOI:10.1016/S1473-3099(21)00202-4
PMID:33861968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8043582/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8941/8043582/25305c6c0ffb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8941/8043582/25305c6c0ffb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8941/8043582/25305c6c0ffb/gr1_lrg.jpg

相似文献

1
SARS-CoV-2 incidence and vaccine escape.严重急性呼吸综合征冠状病毒2型发病率与疫苗逃逸
Lancet Infect Dis. 2021 Jul;21(7):913-914. doi: 10.1016/S1473-3099(21)00202-4. Epub 2021 Apr 13.
2
Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.SARS-CoV-2 受体结合域界面的上位性作用及对疫苗逃逸的有利影响
mBio. 2022 Apr 26;13(2):e0013522. doi: 10.1128/mbio.00135-22. Epub 2022 Mar 15.
3
Role of COVID-19 Vaccines in SARS-CoV-2 Variants.新冠病毒疫苗在 SARS-CoV-2 变异株中的作用。
Front Immunol. 2022 May 20;13:898192. doi: 10.3389/fimmu.2022.898192. eCollection 2022.
4
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.分析新加坡成年人接种 2 剂 mRNA COVID-19 或灭活 SARS-CoV-2 疫苗以及接种加强针后的 COVID-19 发病率和严重程度。
JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900.
5
COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.COVID-19 发病率与区域检测策略、疫苗接种覆盖率和疫苗类型的关系。
Viruses. 2023 Oct 30;15(11):2181. doi: 10.3390/v15112181.
6
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应，发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
7
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis.新型冠状病毒2疫苗在真实世界研究中的有效性和安全性：一项系统评价与荟萃分析
Infect Dis Poverty. 2021 Nov 14;10(1):132. doi: 10.1186/s40249-021-00915-3.
8
SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.SARS-CoV-2 引发非无菌免疫，逃避疫苗诱导的免疫：对未来疫苗接种策略的影响。
Eur J Epidemiol. 2023 Mar;38(3):237-242. doi: 10.1007/s10654-023-00965-x. Epub 2023 Feb 4.
9
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex.COVID-19 疫苗序贯接种与 SARS-CoV-2 感染后心肌炎发病风险：按年龄和性别分层。
Circulation. 2022 Sep 6;146(10):743-754. doi: 10.1161/CIRCULATIONAHA.122.059970. Epub 2022 Aug 22.
10
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.

引用本文的文献

1
The speed of vaccination rollout and the risk of pathogen adaptation.疫苗接种的推广速度与病原体适应性风险。
J R Soc Interface. 2025 Jul;22(228):20250060. doi: 10.1098/rsif.2025.0060. Epub 2025 Jul 9.
2
Eco-evolutionary dynamics of pathogen immune-escape: deriving a population-level phylodynamic curve.病原体免疫逃逸的生态进化动力学：推导群体水平的系统发育动力学曲线。
J R Soc Interface. 2025 Apr;22(225):20240675. doi: 10.1098/rsif.2024.0675. Epub 2025 Apr 2.
3
Learning from the COVID-19 pandemic: A systematic review of mathematical vaccine prioritization models.

本文引用的文献

1
Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model.异质人群中的疫苗逃逸：基于一个简单模型对严重急性呼吸综合征冠状病毒2的见解
R Soc Open Sci. 2021 Jul 14;8(7):210530. doi: 10.1098/rsos.210530. eCollection 2021 Jul.
2
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination.对 SARS-CoV-2 进化的担忧不应阻碍疫苗接种工作的开展。
Nat Rev Immunol. 2021 May;21(5):330-335. doi: 10.1038/s41577-021-00544-9. Epub 2021 Apr 1.
3
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes.
从新冠疫情中学习：数学疫苗优先排序模型的系统综述
Infect Dis Model. 2024 May 15;9(4):1057-1080. doi: 10.1016/j.idm.2024.05.005. eCollection 2024 Dec.
4
Early mutational signatures and transmissibility of SARS-CoV-2 Gamma and Lambda variants in Chile.智利 SARS-CoV-2 Gamma 和 Lambda 变异株的早期突变特征和传播性。
Sci Rep. 2024 Jul 11;14(1):16000. doi: 10.1038/s41598-024-66885-2.
5
Impact of Vaccination and Nonpharmaceutical Interventions With Possible COVID-19 Viral Evolutions Using an Agent-Based Simulation.基于主体模拟的疫苗接种和非药物干预对可能的新冠病毒进化的影响
AJPM Focus. 2023 Oct 10;3(1):100155. doi: 10.1016/j.focus.2023.100155. eCollection 2024 Feb.
6
Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 as a case study.分析病毒爆发的风险和先发制人的控制：以 SARS-CoV-2 为例，考虑到宿主内动力学。
Proc Natl Acad Sci U S A. 2023 Oct 10;120(41):e2305451120. doi: 10.1073/pnas.2305451120. Epub 2023 Oct 3.
7
Evolutionary implications of SARS-CoV-2 vaccination for the future design of vaccination strategies.SARS-CoV-2疫苗接种对未来疫苗接种策略设计的进化意义。
Commun Med (Lond). 2023 Jun 19;3(1):86. doi: 10.1038/s43856-023-00320-x.
8
Vaccine hesitancy promotes emergence of new SARS-CoV-2 variants.疫苗犹豫助长了新的 SARS-CoV-2 变体出现。
J Theor Biol. 2023 Aug 7;570:111522. doi: 10.1016/j.jtbi.2023.111522. Epub 2023 May 18.
9
Non-pharmaceutical interventions and the emergence of pathogen variants.非药物干预措施与病原体变体的出现。
Evol Med Public Health. 2022 Dec 19;11(1):80-89. doi: 10.1093/emph/eoac043. eCollection 2023.
10
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants.在 SARS-CoV-2 变异株中，普遍存在且免疫优势的 CD8 T 细胞表位是保守的。
Cell Rep. 2023 Jan 31;42(1):111995. doi: 10.1016/j.celrep.2023.111995. Epub 2023 Jan 9.
SARS-CoV-2 疫苗接种方案的流行病学和进化考虑。
Science. 2021 Apr 23;372(6540):363-370. doi: 10.1126/science.abg8663. Epub 2021 Mar 9.
4
The Case Against Delaying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine Boosting Doses.反对延迟严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗加强针接种的理由
Clin Infect Dis. 2021 Oct 5;73(7):1321-1323. doi: 10.1093/cid/ciab070.
5
An exceptional vaccination policy in exceptional circumstances.特殊情况下的特殊疫苗接种政策。
Lancet Infect Dis. 2021 Feb;21(2):149. doi: 10.1016/S1473-3099(21)00008-6. Epub 2021 Jan 15.